Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, et al. Acute Exacerbation of idiopathic pulmonary fibrosis. An International Working Group report. Am J Respir Crit Care Med 2016;194(3):265–75. https://www.ncbi.nlm.nih.gov/pubmed/27299520
Idiopathic Pulmonary Fibrosis Clinical Research NetworkPrednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366(21):1968–77. https://www.ncbi.nlm.nih.gov/pubmed/22607134
Jo HE, Troy LK, Keir G, Chambers DC, Holland A, Goh N, et al. Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology 2017;22(7):1436–58. https://www.ncbi.nlm.nih.gov/pubmed/28845557
Jo HE, Prasad JD, Troy LK, Mahar A, Bleasel J, Ellis SJ, et al. Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary. Med J Aust 2018;208(2):82–8. https://www.ncbi.nlm.nih.gov/pubmed/29385965
Jo HE, Troy LK, Keir G, Chambers DC, Holland A, Goh N, et al. Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Sydney: Thoracic Society of Australia and New Zealand and Lung Foundation Australia; 2017. https://onlinelibrary.wiley.com/doi/epdf/10.1111/resp.13146
King TE Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370(22):2083–92. https://www.ncbi.nlm.nih.gov/pubmed/24836312
Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018;198(5):e44–e68. https://www.ncbi.nlm.nih.gov/pubmed/30168753
Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370(22):2071–82. https://www.ncbi.nlm.nih.gov/pubmed/24836310
